Skip to main content

Table 2 Polymerase chain reaction survival rates by week among asymptomatic parasitaemic women treated with sulphadoxine-pyrimethamine at day 0, stratified by gravidity

From: In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi

Uncorrected

Day of follow-up

Primigravid survival rate (95% CI)

Multigravid survival rate (95% CI)

Overall survival rate (95% CI)

7

92.1% (87.3-97.2)

95.4% (91.9-99.1)

93.9% (90.9-96.9)

14

76.5% (68.8-85.0)

88.3% (82.9-94.0)

82.9% (78.2-87.9)

28

58.5% (49.6-69.1)

75.0% (67.6-83.2)

67.5% (61.6-74.0)

35

48.6% (39.3-60.0)

71.2% (63.4-79.9)

61.1% (54.8-68.1)

42

45.8% (36.1-58.2)

68.0% (59.5-77.6)

58.1% (51.5-65.7)

Corrected

Day of follow-up

Primigravid survival rate (95% CI)

Multigravid survival rate (95% CI)

Overall survival rate (95% CI)

7

95.9% (91.0, 100.0)

97.1% (93.9, 100.0)

96.5% (93.6, 99.4)

14

84.2% (76.5, 91.9)

91.4% (86.2, 96.7)

88.2% (83.6, 92.8)

28

68.3% (58.3, 78.3)

82.8% (75.5, 90.1)

76.4% (70.2, 82.6)

35

59.3% (48.1, 70.5)

78.6% (70.6, 86.6)

70.2% (63.5, 77.0)

42

56.0% (43.7, 68.3)

76.4% (67.7, 85.0)

68.7% (61.4, 76.0)

  1. CI: confidence interval.